Compare CAI & PLXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CAI | PLXS |
|---|---|---|
| Founded | 2008 | 1979 |
| Country | United States | United States |
| Employees | 1846 | 20000 |
| Industry | Medical Specialities | Electrical Products |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 5.7B |
| IPO Year | N/A | 1995 |
| Metric | CAI | PLXS |
|---|---|---|
| Price | $18.14 | $226.42 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 4 |
| Target Price | $31.20 | ★ $194.00 |
| AVG Volume (30 Days) | ★ 2.2M | 321.7K |
| Earning Date | 05-12-2026 | 04-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 56.11 |
| EPS | N/A | ★ 1.51 |
| Revenue | ★ N/A | N/A |
| Revenue This Year | $25.24 | $14.31 |
| Revenue Next Year | $22.52 | $8.29 |
| P/E Ratio | ★ N/A | $147.97 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $16.28 | $115.83 |
| 52 Week High | $42.50 | $226.11 |
| Indicator | CAI | PLXS |
|---|---|---|
| Relative Strength Index (RSI) | 44.27 | 67.03 |
| Support Level | $16.98 | $133.51 |
| Resistance Level | $19.66 | N/A |
| Average True Range (ATR) | 1.06 | 9.27 |
| MACD | 0.18 | 2.21 |
| Stochastic Oscillator | 48.81 | 95.74 |
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment. Its integrated lifecycle solutions span design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services for market and disruptive companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The Company operates through three reportable segments: AMER, APAC, and EMEA, with the majority of revenue from the APAC segment.